Zimmer Biomet Holdings, Inc. provided earnings guidance for the full year 2024. The company expects 2024 reported revenue change to be 4.5% - 5.5%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
121.4 USD | +0.72% | +0.96% | -0.22% |
03/05 | Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142 | MT |
03/05 | UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.22% | 24.98B | |
-3.54% | 185B | |
-0.58% | 109B | |
-2.74% | 68.54B | |
+4.84% | 51.74B | |
+10.40% | 45.22B | |
+3.12% | 41.74B | |
+2.87% | 26.69B | |
+4.61% | 26.83B | |
+11.62% | 25.63B |
- Stock Market
- Equities
- ZBH Stock
- News Zimmer Biomet Holdings, Inc.
- Zimmer Biomet Holdings, Inc. Provides Earnings Guidance for the Full Year 2024